, Volume 229, Issue 3, pp 527–538 | Cite as

Methamphetamine-induced increases in putamen gray matter associate with inhibitory control

  • Stephanie M. Groman
  • Angelica M. Morales
  • Buyean Lee
  • Edythe D. London
  • James David Jentsch
Original Investigation



Problematic drug use is associated with difficulty in exerting self-control over behaviors, and this difficulty may be a consequence of atypical morphometric characteristics that are exhibited by drug-experienced individuals. The extent to which these structural abnormalities result from drug use or reflect neurobiological risk factors that predate drug use, however, is unknown.


The purpose of this study is to determine how methamphetamine affects corticostriatal structure and how drug-induced changes relate to alterations in inhibitory control.


Structural magnetic resonance images and positron emission tomography (PET) scans, assessing dopamine D2-like receptor and transporter availability, were acquired in monkeys trained to acquire, retain, and reverse three-choice visual discrimination problems before and after exposure to an escalating dose regimen of methamphetamine (or saline, as a control). Voxel-based morphometry was used to compare changes in corticostriatal gray matter between methamphetamine- and saline-exposed monkeys. The change in gray matter before and after the dosing regimen was compared to the change in the behavioral performance and in dopaminergic markers measured with PET.


Methamphetamine exposure, compared to saline, increased gray matter within the right putamen. These changes were positively correlated with changes in performance of methamphetamine-exposed monkeys in the reversal phase, and were negatively correlated with alterations in D2-like receptor and DAT availability.


The results provide the first evidence that exposure to a methamphetamine dosing regimen that resembles human use alters the structural integrity of the striatum and that gray-matter abnormalities detected in human methamphetamine users are due, at least in part, to the pharmacological effects of drug experience.


Gray matter Striatum Prefrontal cortex Inhibitory control Methamphetamine Addiction Dopamine 



This study was supported primarily by Public Health Service grants P20-DA022539, R03-DA020598, T32-DA024635, F31-DA028812, and F31-DA033117 with additional support from the Consortium for Neuropsychiatric Phenomics at UCLA. The Consortium is funded by PHS grants UL1-DE019580 and RL1-MH083270.


  1. Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV (2006) Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend 81:313–322CrossRefPubMedGoogle Scholar
  2. Anker JJ, Perry JL, Gliddon LA, Carroll ME (2009) Impulsivity predicts the escalation of cocaine self-administration in rats. Pharmacol Biochem Behav 93:343–348CrossRefPubMedGoogle Scholar
  3. Asanuma M, Tsuji T, Miyazaki I, Miyoshi K, Ogawa N (2003) Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug. Neurosci Lett 352:13–16CrossRefPubMedGoogle Scholar
  4. Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC (2011) A reproducible evaluation of ANTs similarity metric performance in brain image registration. NeuroImage 54:2033–2044CrossRefPubMedGoogle Scholar
  5. Baicy K, London ED (2007) Corticolimbic dysregulation and chronic methamphetamine abuse. Addiction 102(Suppl 1):5–15CrossRefPubMedGoogle Scholar
  6. Bellebaum C, Koch B, Schwarz M, Daum I (2008) Focal basal ganglia lesions are associated with impairments in reward-based reversal learning. Brain 131:829–841CrossRefPubMedGoogle Scholar
  7. Benegal V, Antony G, Venkatasubramanian G, Jayakumar PN (2007) Gray matter volume abnormalities and externalizing symptoms in subjects at high risk for alcohol dependence. Addict Biol 12:122–132CrossRefPubMedGoogle Scholar
  8. Castane A, Theobald DE, Robbins TW (2010) Selective lesions of the dorsomedial striatum impair serial spatial reversal learning in rats. Behav Brain Res 210:74–83CrossRefPubMedGoogle Scholar
  9. Chang L, Cloak C, Patterson K, Grob C, Miller EN, Ernst T (2005) Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol Psychiatry 57:967–974CrossRefPubMedGoogle Scholar
  10. Chang L, Alicata D, Ernst T, Volkow N (2007) Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102(Suppl 1):16–32CrossRefPubMedGoogle Scholar
  11. Churchwell JC, Carey PD, Ferrett HL, Stein DJ, Yurgelun-Todd DA (2012) Abnormal striatal circuitry and intensified novelty seeking among adolescents who abuse methamphetamine and cannabis. Dev Neurosci 34:310–317CrossRefPubMedGoogle Scholar
  12. Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC (2004) Cognitive inflexibility after prefrontal serotonin depletion. Science 304:878–880CrossRefPubMedGoogle Scholar
  13. Clarke HF, Hill GJ, Robbins TW, Roberts AC (2011) Dopamine, but not serotonin, regulates reversal learning in the marmoset caudate nucleus. J Neurosci 31:4290–4297CrossRefPubMedGoogle Scholar
  14. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K, Pena Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron JC, Everitt BJ, Robbins TW (2007) Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315:1267–1270CrossRefPubMedGoogle Scholar
  15. Dias R, Robbins TW, Roberts AC (1996) Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset. Behav Neurosci 110:872–886CrossRefPubMedGoogle Scholar
  16. Diergaarde L, Pattij T, Poortvliet I, Hogenboom F, de Vries W, Schoffelmeer AN, De Vries TJ (2008) Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol Psychiatry 63:301–308CrossRefPubMedGoogle Scholar
  17. Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET (2012) Abnormal brain structure implicated in stimulant drug addiction. Science 335:601–604CrossRefPubMedGoogle Scholar
  18. Fears SC, Melega WP, Service SK, Lee C, Chen K, Tu Z, Jorgensen MJ, Fairbanks LA, Cantor RM, Freimer NB, Woods RP (2009) Identifying heritable brain phenotypes in an extended pedigree of vervet monkeys. J Neurosci 29:2867–2875CrossRefPubMedGoogle Scholar
  19. Fellows LK, Farah MJ (2003) Ventromedial frontal cortex mediates affective shifting in humans: evidence from a reversal learning paradigm. Brain 126:1830–1837CrossRefPubMedGoogle Scholar
  20. Ghahremani DG, Tabibnia G, Monterosso J, Hellemann G, Poldrack RA, London ED (2011) Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. Neuropsychopharmacology 36:950–959CrossRefPubMedGoogle Scholar
  21. Groman SM, Jentsch JD (2011) Cognitive control and the dopamine D(2)-like receptor: a dimensional understanding of addiction. Depress Anxiety 29:295–306CrossRefPubMedGoogle Scholar
  22. Groman SM, Jentsch JD (2013) Identifying the molecular basis of inhibitory control deficits in addictions: neuroimaging in non-human primates. Curr Opin Neurobiol. doi:  10.1016/j.conb.2013.03.001
  23. Groman SM, Lee B, London ED, Mandelkern MA, James AS, Feiler K, Rivera R, Dahlbom M, Sossi V, Vandervoort E, Jentsch JD (2011) Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning. J Neurosci 31:7291–7299CrossRefPubMedGoogle Scholar
  24. Groman SM, Lee B, Seu E, James AS, Feiler K, Mandelkern MA, London ED, Jentsch JD (2012) Dysregulation of d2-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure. J Neurosci 32:5843–5852CrossRefPubMedGoogle Scholar
  25. Haldane M, Cunningham G, Androutsos C, Frangou S (2008) Structural brain correlates of response inhibition in bipolar disorder I. J Psychopharmacol 22:138–143CrossRefPubMedGoogle Scholar
  26. Han E, Paulus MP, Wittmann M, Chung H, Song JM (2011) Hair analysis and self-report of methamphetamine use by methamphetamine dependent individuals. J Chromatogr B Analyt Technol Biomed Life Sci 879:541–547CrossRefPubMedGoogle Scholar
  27. Ichise M, Liow JS, Lu JQ, Takano A, Model K, Toyama H, Suhara T, Suzuki K, Innis RB, Carson RE (2003) Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23:1096–1112CrossRefPubMedGoogle Scholar
  28. Izquierdo A, Jentsch JD (2012) Reversal learning as a measure of impulsive and compulsive behavior in addictions. Psychopharmacol (Berl) 219:607–620CrossRefGoogle Scholar
  29. Jan RK, Lin JC, Miles SW, Kydd RR, Russell BR (2012) Striatal volume increases in active methamphetamine-dependent individuals and correlation with cognitive performance. Brain Sci 2:553–572CrossRefGoogle Scholar
  30. Jedynak JP, Uslaner JM, Esteban JA, Robinson TE (2007) Methamphetamine-induced structural plasticity in the dorsal striatum. Eur J Neurosci 25:847–853CrossRefPubMedGoogle Scholar
  31. Jentsch JD, Taylor JR (1999) Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacol (Berl) 146:373–390CrossRefGoogle Scholar
  32. Jentsch JD, Olausson P, De La Garza R 2nd, Taylor JR (2002) Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys. Neuropsychopharmacology 26:183–190CrossRefPubMedGoogle Scholar
  33. Jernigan TL, Gamst AC, Archibald SL, Fennema-Notestine C, Mindt MR, Marcotte TD, Heaton RK, Ellis RJ, Grant I (2005) Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry 162:1461–1472CrossRefPubMedGoogle Scholar
  34. Kousik SM, Graves SM, Napier TC, Zhao C, Carvey PM (2011) Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction. Neuroreport 22:923–928CrossRefPubMedGoogle Scholar
  35. Kousik SM, Napier TC, Carvey PM (2012) The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation. Front Pharmacol 3:121CrossRefPubMedGoogle Scholar
  36. McLaren DG, Kosmatka KJ, Kastman EK, Bendlin BB, Johnson SC (2010) Rhesus macaque brain morphometry: a methodological comparison of voxel-wise approaches. Methods 50:157–165CrossRefPubMedGoogle Scholar
  37. Morales AM, Lee B, Hellemann G, O’Neill J, London ED (2012) Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Drug Alcohol Depend 125:230–238CrossRefPubMedGoogle Scholar
  38. Moreno-Lopez L, Catena A, Fernandez-Serrano MJ, Delgado-Rico E, Stamatakis EA, Perez-Garcia M, Verdejo-Garcia A (2012) Trait impulsivity and prefrontal gray matter reductions in cocaine dependent individuals. Drug Alcohol Depend 125:208–214CrossRefPubMedGoogle Scholar
  39. Nader MA, Morgan D, Gage HD, Nader SH, Calhoun TL, Buchheimer N, Ehrenkaufer R, Mach RH (2006) PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci 9:1050–1056CrossRefPubMedGoogle Scholar
  40. Perry JL, Nelson SE, Carroll ME (2008) Impulsive choice as a predictor of acquisition of IV cocaine self- administration and reinstatement of cocaine-seeking behavior in male and female rats. Exp Clin Psychopharmacol 16:165–177CrossRefPubMedGoogle Scholar
  41. Porter JN, Olsen AS, Gurnsey K, Dugan BP, Jedema HP, Bradberry CW (2011) Chronic cocaine self-administration in rhesus monkeys: impact on associative learning, cognitive control, and working memory. J Neurosci 31:4926–4934CrossRefPubMedGoogle Scholar
  42. Porter JN, Gurnsey K, Jedema HP, Bradberry CW (2012) Latent vulnerability in cognitive performance following chronic cocaine self-administration in rhesus monkeys. Psychopharmacol (Berl) 226:139–146CrossRefGoogle Scholar
  43. Rygula R, Walker SC, Clarke HF, Robbins TW, Roberts AC (2010) Differential contributions of the primate ventrolateral prefrontal and orbitofrontal cortex to serial reversal learning. J Neurosci 30:14552–14559CrossRefPubMedGoogle Scholar
  44. Schoenbaum G, Setlow B (2005) Cocaine makes actions insensitive to outcomes but not extinction: implications for altered orbitofrontal-amygdalar function. Cereb Cortex 15:1162–1169CrossRefPubMedGoogle Scholar
  45. Schoenbaum G, Saddoris MP, Ramus SJ, Shaham Y, Setlow B (2004) Cocaine-experienced rats exhibit learning deficits in a task sensitive to orbitofrontal cortex lesions. Eur J Neurosci 19:1997–2002CrossRefPubMedGoogle Scholar
  46. Sekine Y, Ouchi Y, Sugihara G, Takei N, Yoshikawa E, Nakamura K, Iwata Y, Tsuchiya KJ, Suda S, Suzuki K, Kawai M, Takebayashi K, Yamamoto S, Matsuzaki H, Ueki T, Mori N, Gold MS, Cadet JL (2008) Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 28:5756–5761CrossRefPubMedGoogle Scholar
  47. Smith SM, Nichols TE (2009) Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 44:83–98CrossRefPubMedGoogle Scholar
  48. Sridharan A, Willette AA, Bendlin BB, Alexander AL, Coe CL, Voytko ML, Colman RJ, Kemnitz JW, Weindruch RH, Johnson SC (2012) Brain volumetric and microstructural correlates of executive and motor performance in aged rhesus monkeys. Front Aging Neurosci 4:31CrossRefPubMedGoogle Scholar
  49. Stone JM, Bhattacharyya S, Barker GJ, McGuire PK (2012) Substance use and regional gray matter volume in individuals at high risk of psychosis. Eur Neuropsychopharmacol 22:114–122CrossRefPubMedGoogle Scholar
  50. Tabibnia G, Monterosso JR, Baicy K, Aron AR, Poldrack RA, Chakrapani S, Lee B, London ED (2011) Different forms of self-control share a neurocognitive substrate. J Neurosci 31:4805–4810CrossRefPubMedGoogle Scholar
  51. Thomas DM, Kuhn DM (2005) Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine. J Neurochem 92:790–797CrossRefPubMedGoogle Scholar
  52. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24:6028–6036CrossRefPubMedGoogle Scholar
  53. Tulloch IK, Afanador L, Zhu J, Angulo JA (2011) Methamphetamine induces striatal cell death followed by the generation of new cells and a second round of cell death in mice. Curr Neuropharmacol 9:79–83CrossRefPubMedGoogle Scholar
  54. Turner TH, LaRowe S, Horner MD, Herron J, Malcolm R (2009) Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. J Subst Abus Treat 37:328–334CrossRefGoogle Scholar
  55. Yuan Y, Zhu Z, Shi J, Zou Z, Yuan F, Liu Y, Lee TM, Weng X (2009) Gray matter density negatively correlates with duration of heroin use in young lifetime heroin-dependent individuals. Brain Cogn 71:223–228CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Stephanie M. Groman
    • 1
  • Angelica M. Morales
    • 2
  • Buyean Lee
    • 2
  • Edythe D. London
    • 2
    • 3
  • James David Jentsch
    • 1
    • 2
  1. 1.Department of PsychologyUCLA Department of PsychologyLos AngelesUSA
  2. 2.Department of Psychiatry & Biobehavioral SciencesUniversity of CaliforniaLos AngelesUSA
  3. 3.Department of Medical and Molecular PharmacologyUniversity of CaliforniaLos AngelesUSA

Personalised recommendations